Needle Biopsy Market Research Report- Global Forecast till 2027

Needle Biopsy Market Share, Growth And Trends Analysis By Type (Fine-Needle Aspiration Biopsy, Core Needle Biopsy, Vacuum-Assisted Biopsy, Image-Guided Biopsy) By Utility (Disposable, Reusable), By Applications (Tumor, Infection, Inflammation, Others) - Global Forecast Till 2027

ID: MRFR/MED/2542-HCR | February 2021 | Region: Global | 110 pages

Please note that the assessment period of the report has been updated from 2017-2023 to 2020-2027. Cordially fill Sample form for the updated data.

Market Synopsis of Global Needle Biopsy Market:


A Needle Biopsy is a procedure to extract a sample of cells from the body by inserting a needle in the appropriate sampling site. The extracted tissue is then used for laboratory testing so as to find any abnormality. The market for needle biopsy is growing due to market driving factors such as cancers, infections etc.


The development of ultrasensitive imaging technologies such as Magnetic Resonance Imaging (MRI), Computed Tomography (CT) etc. are the market constraints. However the emergence of liquid biopsy is the single largest threat to the future of needle biopsy.


Considering all these factors the market for Needle Biopsy is expected to reach $ 677 million by the end of 2023, this market is projected to be growing at a CAGR of ~ 5.2 % during 2017-2023.


Study objectives:



  • To provide a detailed analysis of the market structure along with estimated future growth forecast for the next six years about various segments and sub-segments of the global needle biopsy market.

  • To provide insights about factors affecting the market growth.

  • To analyze the global needle biopsy market based on various factors - Price Analysis, Supply Chain Analysis, Porters Five Force analysis etc.

  • To provide past and estimated future revenue of the market’s segments and sub-segments with respect to four main geographies and their countries - the Americas, Europe, Asia Pacific along with Middle East & Africa.

  • To provide country level analysis of the market with respect to the current market size and future growth prospects.

  • To provide country level analysis of the market which includes segmentation by type, utility and applications.

  • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape of the market.

  • To track and analyze developments which are competitive in nature such as joint ventures, strategic alliances, mergers and acquisitions, new product developments along with research and developments that are currently taking place in the global needle biopsy markets.


Research methodology Research methodology needle biopsy markets


Intended Audience



  • Global needle biopsy, manufacturers & suppliers

  • Research and development (R&D) companies

  • Market research and consulting service providers

  • Academic institutes and universities


 


Figure 1         Global Needle Biopsy Market by Applications, 2016 (% Market Share) Needle Biopsy Market by Applications, 2016


Segments:


The global Needle Biopsy Market is segmented on the basis of type and applications. Based on type, the market has been segmented as fine-needle aspiration biopsy, core needle biopsy, vacuum-assisted biopsy and image-guided biopsy. Based on the utility, the market has been segmented as disposable and reusable. Based on the applications, the market has been segmented as tumor, infection, inflammation and others.


Regional analysis


US accounts for the maximum market share due to favorable reimbursement scenarios and greater expenditure on healthcare. The faster market uptake of new technology in the US is also an important driver of the market for global needle biopsy. Europe is the second largest market due to large disposable income and rising awareness. Asia Pacific region is the fastest growing region because of large unmet needs which is led by China and India. The Middle East & Africa market is led by the gulf nations particularly Saudi Arabia and UAE. The poor regions of Africa are expected to be a laggard due to poor economic and political conditions and poor healthcare penetration.


Key players of Global Needle Biopsy Market:


Key players profiled in the report are Boston Scientific Corporation, Cook Medical, CareFusion Corporation, Hologic, Inc., and Cardinal Health, Inc., Medax, C. R. Bard, Inc., Möller Medical GmbH, Becton, Dickinson and Company, Hakko co. ltd., Kompass, Argon Medical Devices, Inc. and others. The report for Global Needle Biopsy Market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.



Frequently Asked Questions (FAQ) :


The Needle Biopsy Market CAGR Would be 5.2% During The Forecast Period.

The US is the largest North American market.

Players involved are Cook Medical, Boston Scientific Corporation, Kompass, Argon Medical Devices, Inc. Hologic, Inc., and Cardinal Health, Inc., CareFusion Corporation, Möller Medical GmbH, Becton, Dickinson and Company, Hakko co. ltd., Medax, C. R. Bard, Inc., and others.

The Liquid Biopsy Market Could Be A Substitute For The Market And Deter Its Growth.

Table of Contents

1. INTRODUCTION

1.1 DEFINITION

1.2 SCOPE OF STUDY

1.2.1 RESEARCH OBJECTIVE

1.2.2 ASSUMPTIONS & LIMITATIONS

1.2.2.1 ASSUMPTIONS

1.2.2.2 LIMITATIONS

1.3 MARKET STRUCTURE:

2. RESEARCH METHODOLOGY

2.1 RESEARCH PROCESS:

2.2 PRIMARY RESEARCH

2.3 SECONDARY RESEARCH:

3. MARKET DYNAMICS

3.1 DRIVERS

3.2 RESTRAINTS

3.3 OPPORTUNITIES

3.4 MACROECONOMIC INDICATORS

4. MARKET FACTOR ANALYSIS

4.1 PORTERS FIVE FORCES MODEL

4.2 BARGAINING POWER OF SUPPLIERS

4.3 BARGAINING POWER OF BUYERS

4.4 THREAT OF NEW ENTRANTS

4.5 THREAT OF SUBSTITUTES

4.6 INTENSITY OF RIVALRY

5. GLOBAL NEEDLE BIOPSY MARKET, BY TYPE

5.1 FINE-NEEDLE ASPIRATION BIOPSY

5.2 CORE NEEDLE BIOPSY

5.3 VACUUM-ASSISTED BIOPSY

5.4 IMAGE-GUIDED BIOPSY

6. GLOBAL NEEDLE BIOPSY MARKET, BY UTILITY

6.1 DISPOSABLE

6.2 REUSABLE

7. GLOBAL NEEDLE BIOPSY MARKET, BY APPLICATIONS

7.1 TUMOR

7.2 INFECTION

7.3 INFLAMMATION

7.4 OTHERS

8. GLOBAL NEEDLE BIOPSY MARKET, BY REGION

8.1 NORTH AMERICA

8.1.1 INTRODUCTION

8.2 EUROPE

8.2.1 INTRODUCTION

8.3 ASIA-PACIFIC

8.3.1 INTRODUCTION

8.4 MIDDLE EAST & AFRICA

8.4.1 INTRODUCTION

9. COMPETITIVE LANDSCAPE

9.1 MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS

9.1.1 STRATEGIC PARTNERSHIP

9.1.2 MERGER & ACQUISITION

10. COMPANY PROFILE

10.1 BOSTON SCIENTIFIC CORPORATION

10.1.1 OVERVIEW

10.1.2 PRODUCT OVERVIEW

10.1.3 FINANCIALS

10.1.4 KEY DEVELOPMENTS

10.2 COOK MEDICAL

10.2.1 OVERVIEW

10.2.2 PRODUCT OVERVIEW

10.2.3 FINANCIALS

10.2.4 KEY DEVELOPMENTS

10.3 CAREFUSION CORPORATION

10.3.1 OVERVIEW

10.3.2 PRODUCT OVERVIEW

10.3.3 FINANCIALS

10.3.4 KEY DEVELOPMENT

10.4 HOLOGIC, INC.

10.4.1 OVERVIEW

10.4.2 PRODUCT OVERVIEW

10.4.3 FINANCIALS

10.4.4 KEY DEVELOPMENTS

10.5 CARDINAL HEALTH, INC.

10.5.1 OVERVIEW

10.5.2 PRODUCT OVERVIEW

10.5.3 FINANCIALS

10.5.4 KEY DEVELOPMENTS

10.6 MEDAX

10.6.1 OVERVIEW

10.6.2 PRODUCT OVERVIEW

10.6.3 FINANCIALS

10.6.4 KEY DEVELOPMENTS

10.7 C. R. BARD

10.7.1 OVERVIEW

10.7.2 PRODUCT OVERVIEW

10.7.3 FINANCIALS

10.7.4 KEY DEVELOPMENTS

10.8 MÖLLER MEDICAL GMBH

10.8.1 OVERVIEW

10.8.2 PRODUCT OVERVIEW

10.8.3 FINANCIALS

10.8.4 KEY DEVELOPMENTS

10.10 BECTON, DICKINSON AND COMPANY

10.10.1 OVERVIEW

10.10.2 PRODUCT OVERVIEW

10.10.3 FINANCIALS

10.10.4 KEY DEVELOPMENTS

10.10 HAKKO CO. LTD.

10.10.1 OVERVIEW

10.10.2 PRODUCT OVERVIEW

10.10.3 FINANCIALS

10.10.4 KEY DEVELOPMENTS

10.11 KOMPASS

10.11.1 OVERVIEW

10.11.2 PRODUCT OVERVIEW

10.11.3 FINANCIALS

10.11.4 KEY DEVELOPMENTS

10.12 OTHERS


CONCLUSION


11.1 KEY FINDINGS

11.1.1 FROM CEO’S VIEWPOINT

11.1.2 UNMET NEEDS OF THE MARKET

11.2 KEY COMPANIES TO WATCH

11.3 PREDICTION OF NEEDLE BIOPSY INDUSTRY

12. APPENDIX